Golden State Wealth Management, LLC Aurinia Pharmaceuticals Inc. Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 263 shares of AUPH stock, worth $2,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
263Holding current value
$2,140% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
209Shares Held
58.1MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$75.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$66.7 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$58.8 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.3 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$24 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.16B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...